Russell Rosenberg, PhD

At SLEEP 2018, Dr. Rosenberg describes phase I trials that assessed patients' driving performance, ability to be awakened, and postural stability after taking the investigational sleep-wake regulation drug lemborexant, compared with active and placebo comparators.


Limelight Video

Next Article:

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge